---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000649991.md"
description: "📢 𝐉𝐔𝐒𝐓 𝐈𝐍: Novo Nordisk Reports New Positive Data for Higher-Dose Wegovy Trial - $Novo Nordisk AS(NVO.US) $Hims & Hers Health(HIMS.US) $Eli Lilly(LLY.US) 👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:➤  Novo reports new 𝐒𝐓𝐄𝐏 𝐔𝐏 trial data for 𝐖𝐞𝐠𝐨𝐯𝐲 𝟕.𝟐 𝐦𝐠.➤  Patients lost average 𝟐𝟏% body weight over 𝟕𝟐 weeks.➤  Higher dose outperformed Wegovy 𝟐.𝟒 𝐦𝐠 and placebo groups.➤  Early responders on 𝟕.𝟐 𝐦𝐠 lost nearly 𝟐𝟖% body weight.➤  Study included 𝟏,𝟒𝟎𝟎+ adults with obesity without diabetes.➤  𝟖𝟒% of weight loss came from reduced 𝐟𝐚𝐭 𝐦𝐚𝐬𝐬.➤  Participants maintained 𝐦𝐮𝐬𝐜𝐥𝐞 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡 despite significant weight reduction."
datetime: "2026-05-12T10:37:25.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000649991.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000649991.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000649991.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# 📢 𝐉𝐔𝐒𝐓 𝐈𝐍: Novo Nordisk Reports New Positive Data …


### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**